Genprex secures exclusive gene therapy license for cancer By Investing.com
AUSTIN, Texas - Genprex , Inc. (NASDAQ: NASDAQ:), a clinical-stage gene therapy company, has obtained an exclusive license from the...
Read moreDetailsLatest Post
KPMG to spend $100 million on AI partnership with Google Cloud
By Kenrick Cai SAN FRANCISCO (Reuters) - - KPMG said on Wednesday it would spend $100 million over the next...
Read moreDetails
Philippine hatchling stirs hope for endangered eagle
MANILA, Philippines — A baby Philippine Eagle has hatched in the Southeast Asian country with the help of artificial insemination,...
Read moreDetails
Surgeon general says U.S. smoking rates have tumbled, but not for everyone
Although the United States has made significant headway in curbing cigarette smoking and secondhand smoke exposure, a new report finds...
Read moreDetails
Israeli posturing over Lebanon ceasefire “not the reality”
Menachem Klein talks about Netanyahu’s flawed strategy for imposing a ceasefire between Israel and Hezbollah. Source link
Read moreDetails
